Medical Care Technologies Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Marshall Perkins
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 1910 S Stapley Drive Mesa AZ United States of America 85204
- IPO Date
- Feb 17, 2009
- CIK
- 0001404593
- Website
- mdcestock.com
- Similar Companies
- Business
- Medical Care Technologies Inc. specializes in developing proprietary AI-driven healthcare technologies and medical equipment aimed at enhancing early detection, patient outcomes, and healthcare provider support through innovative diagnostic tools. The company's core products include AI-powered diagnostic platforms transforming smartphones into screening tools for conditions such as melanoma, wound infections, and mental health issues; continuous glucose monitors for diabetes management; CPAP and BiPAP devices for sleep apnea; invasive and non-invasive home ventilator systems; durable oxygen supplies; and pharmaceutical and nutraceutical products distributed through retail and medical channels. Additionally, the company operates subsidiaries like Infinite Auctions LLC, an auction house for sports and entertainment memorabilia, and Real Game Used LLC, an AI-enhanced authentication service for collectibles that contributes to its revenue streams. Founded in 1990 and headquartered in Mesa, Arizona, Medical Care Technologies Inc. operates in the healthcare technology, medical equipment, and digital health sectors with a focus on the North American market. Its business segments encompass AI health analytics and mobile app ecosystems targeting digital health worth billions, alongside traditional medical equipment and pharmaceutical distribution. The company is positioning itself as a leader in AI-powered health tech innovation while maintaining diversified income sources through its collectibles auction and authentication businesses. Recent major developments include the company's strategic pivot toward AI-driven diagnostic healthcare platforms with a provisional patent filed for its AI diagnostic smartphone technology. Its subsidiaries have demonstrated strong financial performance with over $848,000 revenue in 2025 supporting the company’s transition to debt-free status by year-end. The company has expanded its AI health app ecosystem to address a rapidly growing digital health market, focusing on health, diet, nutrition, and lifestyle tracking technologies. The CEO's recent significant insider stock purchase reflects confidence in the company’s strategic direction and growth potential. These advances mark a robust operational and financial foundation enabling continued innovation and market expansion in health technology and digital wellness domains.
Company News
Medical Care Technologies Inc. (OTCID:MDCE) Activates Volunteer Intake for Melanoma Scan Beta After Launching First Human-Submitted Dataset Initiative
Medical Care Technologies Inc. (OTCID:MDCE) Prepares First Custom StrainScan Pro Demos for Enterprise Agricultural Clients
Medical Cate Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Targets the Visual Race Against Time in America's Deadliest Common Skin Cancer
Medical Care Technologies Inc. (OTCID:MDCE) Centers StrainScan Pro on Multi-Trillion-Dollar Agriculture and Foodservice Markets
Medical Care Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Seeks First Volunteer Cohorts for Human-Submitted Image Dataset Testing
Medical Care Technologies (OTC PINK:MDCE) Advances AI Longitudinal Body-Map Monitoring Capabilities Within its Melanoma Scan Beta App
StrainScan Pro Demonstrates Versatility as MDCE Applies Core AI Vision Technology Across Regulated Retail and Large-Scale Agriculture (OTCID:MDCE)
MDCE Highlights StrainScan Pro's Enterprise-Ready Agricultural AI Tech Optimized for Rapid Multi-Location Rollout on iPad Air (OTC PINK:MDCE)
MDCE Advances Continuously Learning AI Models Within StrainScan Pro for Greater Visual Accuracy Across Agricultural and Retail Environments (OTC PINK:MDCE)
MDCE Advances StrainScan Pro as Scalable Enterprise Platform for Multi-Billion-Dollar Retail and Agricultural Operators (OTCID:MDCE)
StrainScan Pro Enables Farm-to-Plate Freshness and Quality Tracking Across the Food Supply Chain (OTCID:MDCE)
MDCE's StrainScan Pro Targets Early Pest and Crop Illness Detection in Multi-Trillion-Dollar Agriculture Sector (OTCID:MDCE)
MDCE Introduces a Higher Standard for Strain Integrity, Potency Verification and Agricultural Quality Control with StrainScan Pro (OTCID:MDCE)
MDCE Highlights StrainScan Pro for Multi-Billion-Dollar Cannabis Dispensary Sector with Enterprise iPad Air Solution (OTC Pink:MDCE)
MDCE Positions StrainScan Pro for $4 Trillion Global Foodservice Market via Enterprise iPad Air Installations (OTC Pink:MDCE)
Medical Care Technologies Advances Into $300B+ Food Logistics Sector with iPad Air-Ready AI Quality Platform (OTC PINK:MDCE)
MDCE Targets $5 Trillion Global Agriculture Market with StrainScan Pro Enterprise Deployment on iPad Air (OTC Pink:MDCE)
Medical Care Technologies (OTCID:MDCE) Launches StrainScan Pro - Expanding AI Vision Platform into High-Value Agricultural & Food Quality Control Markets
Medical Care Technologies Continues Rigorous Testing of MDCE Melanoma Scan While Evaluating Expansion Opportunities (OTC Pink:MDCE)
Medical Care Technologies Demonstrates Broad Monetization Power Across AI Vision, Software Development and Digital Platforms (OTC Pink:MDCE)